首页> 外文会议>Society for Biomaterials annual meeting and exposition >Delivery of Bupivacaine and Tolfenamic Acid from Ultra-High Molecular Weight Polyethylene: Multimodal Pain Relief and Synergistic Antibacterial Properties from Total Joint Implants
【24h】

Delivery of Bupivacaine and Tolfenamic Acid from Ultra-High Molecular Weight Polyethylene: Multimodal Pain Relief and Synergistic Antibacterial Properties from Total Joint Implants

机译:来自超高分子量聚乙烯的Bupivaine和脱酚酸:来自总关联植入物的多模式疼痛缓解和协同抗菌性能

获取原文

摘要

Typical post-arthroplasty bolus injections of local anesthetics and NSAIDs range from 30-400 mg and 30 mg, respectively. This study shows that analgesic-loaded UHMWPE can deliver clinically-relevant doses of both bupivacaine and tolfenamic acid. We show for the first time that bupivacaine and tolfenamic acid possess synergistic effects against bacteria when released from UHMWPE. These biomaterials may prove to be valuable tools for simultaneously managing post-operative pain and addressing periprosthetic joint infection after total joint arthroplasty.
机译:典型的关节置换术推注分别从30-400mg和30 mg的局部麻醉剂和NSAID分别注射。本研究表明,镇痛负载的UHMWPE可以临床相关剂量的Bupivacaine和脱酚酸。我们首次展示了Bupivacaine和Tolfenamic acid在从UHMWPE释放时对细菌具有协同作用。这些生物材料可能被证明是同时管理术后疼痛和解决总关节置换术后的患者关节感染的有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号